Resilience learning from the COVID-19 pandemic and its relevance for routine immunization programs.

IF 4.8 3区 医学 Q1 IMMUNOLOGY Expert Review of Vaccines Pub Date : 2022-11-01 DOI:10.1080/14760584.2022.2116007
Oluyemisi Falope, Mawuli K Nyaku, Ciara O'Rourke, Lindsay V Hermany, Brittany Plavchak, Josephine Mauskopf, Louise Hartley, Margaret E Kruk
{"title":"Resilience learning from the COVID-19 pandemic and its relevance for routine immunization programs.","authors":"Oluyemisi Falope,&nbsp;Mawuli K Nyaku,&nbsp;Ciara O'Rourke,&nbsp;Lindsay V Hermany,&nbsp;Brittany Plavchak,&nbsp;Josephine Mauskopf,&nbsp;Louise Hartley,&nbsp;Margaret E Kruk","doi":"10.1080/14760584.2022.2116007","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The COVID-19 pandemic represents a threat that has posed a challenge to public health response and threatens immunization programs globally. Despite recommendations to continue routine immunization services, disruptions have been observed to these and mass vaccination campaigns. This may result in setbacks to immunization initiative successes and a rise in cases of vaccine-preventable diseases.</p><p><strong>Areas covered: </strong>We conducted a systematic literature review to identify studies globally that described how indicators of health system resilience, defined using the Resilient Health System Framework, enabled routine immunizations to continue during the COVID-19 pandemic. A systematic search was conducted in Embase, Web of Science, PsychInfo, medRxiv, bioRxiv, and the gray literature between 1 January 2020, and 12 November 2021. Information was extracted from the studies identified describing how the specific elements of resiliency (being aware, diverse, self-regulating, integrated, and adaptive) were applied to their routine immunization programs.</p><p><strong>Expert opinion: </strong>Our study demonstrates the use of tools that contributed to immunization program resilience during the COVID-19 pandemic in all geographic regions and for countries with different income levels. These tools may help inform preparations for other immunization programs to catch up from the COVID-19 pandemic or mitigate the impact of future threats.</p>","PeriodicalId":12326,"journal":{"name":"Expert Review of Vaccines","volume":"21 11","pages":"1621-1636"},"PeriodicalIF":4.8000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14760584.2022.2116007","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 4

Abstract

Introduction: The COVID-19 pandemic represents a threat that has posed a challenge to public health response and threatens immunization programs globally. Despite recommendations to continue routine immunization services, disruptions have been observed to these and mass vaccination campaigns. This may result in setbacks to immunization initiative successes and a rise in cases of vaccine-preventable diseases.

Areas covered: We conducted a systematic literature review to identify studies globally that described how indicators of health system resilience, defined using the Resilient Health System Framework, enabled routine immunizations to continue during the COVID-19 pandemic. A systematic search was conducted in Embase, Web of Science, PsychInfo, medRxiv, bioRxiv, and the gray literature between 1 January 2020, and 12 November 2021. Information was extracted from the studies identified describing how the specific elements of resiliency (being aware, diverse, self-regulating, integrated, and adaptive) were applied to their routine immunization programs.

Expert opinion: Our study demonstrates the use of tools that contributed to immunization program resilience during the COVID-19 pandemic in all geographic regions and for countries with different income levels. These tools may help inform preparations for other immunization programs to catch up from the COVID-19 pandemic or mitigate the impact of future threats.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
从COVID-19大流行中学到的韧性及其与常规免疫规划的相关性。
2019冠状病毒病大流行是一种威胁,对公共卫生应对构成挑战,并威胁到全球免疫规划。尽管建议继续提供常规免疫接种服务,但这些活动和大规模疫苗接种运动已出现中断。这可能导致免疫倡议的成功受挫,疫苗可预防疾病病例增加。涵盖领域:我们进行了系统的文献综述,以确定全球范围内的研究,这些研究描述了使用弹性卫生系统框架定义的卫生系统弹性指标如何在COVID-19大流行期间继续进行常规免疫接种。在2020年1月1日至2021年11月12日期间,在Embase、Web of Science、PsychInfo、medRxiv、bioRxiv和灰色文献中进行了系统检索。从确定的研究中提取的信息描述了如何将弹性的特定元素(意识,多样性,自我调节,整合和适应性)应用于其常规免疫计划。专家意见:我们的研究表明,在所有地理区域和不同收入水平的国家,在COVID-19大流行期间使用的工具有助于提高免疫规划的复原力。这些工具可能有助于为其他免疫规划的准备工作提供信息,以应对COVID-19大流行或减轻未来威胁的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Expert Review of Vaccines
Expert Review of Vaccines 医学-免疫学
CiteScore
9.10
自引率
3.20%
发文量
136
审稿时长
4-8 weeks
期刊介绍: Expert Review of Vaccines (ISSN 1476-0584) provides expert commentary on the development, application, and clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines for defence against bioterrorism. All articles are subject to rigorous peer-review. The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.
期刊最新文献
Pneumococcal conjugate vaccines in older adults and immunocompromised individuals. Letter to the editor: Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in Germany. A human Lyme disease vaccine: two steps forward on the path to prevention. Exploring determinants of vaccine hesitancy among healthcare professionals: a systematic literature review. Global status of HPV vaccination two decades in: effective, safe and preventing cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1